Longevity Glossary

17α-Estradiol is a stereoisomer of the dominant estrogen 17β-estradiol with much weaker feminizing activity. In the NIA Interventions Testing Program, it consistently extended median lifespan in male mice, possibly via hypothalamic and metabolic effects. Mechanism is incompletely understood and human longevity data do not exist; it is not approved or established as a human anti-aging therapy.

Acarbose is an alpha-glucosidase inhibitor approved for type 2 diabetes mellitus. By blocking intestinal carbohydrate breakdown, it blunts postprandial glucose and insulin spikes and shifts substrate to colonic fermentation. In the NIA Interventions Testing Program, acarbose extended median lifespan in male mice and modestly in females, an effect attributed to glycemic smoothing and microbiome shifts. Off-label longevity use in humans is investigational; gastrointestinal side effects (flatulence, diarrhea) limit tolerability.

Adult stem cells, or somatic stem cells, are undifferentiated cells residing in specific tissue niches that maintain and repair the tissue throughout life. Examples include hematopoietic, mesenchymal, intestinal, and neural stem cells. They are typically multipotent, generating the cell types of their tissue of origin. Their decline with age underlies stem cell exhaustion, making their preservation and rejuvenation a primary goal of longevity and regenerative medicine.

Advanced glycation end-products are stable, often crosslinked compounds formed when sugars react with proteins, lipids, or DNA over time. They accumulate in long-lived tissues such as skin, cartilage, and arterial walls, where they impair elasticity and function. AGEs activate the RAGE receptor, triggering inflammation and oxidative stress. Their build-up is linked to diabetes complications, atherosclerosis, kidney disease, and skin ageing.

Aerobic capacity is the maximum rate of oxygen uptake the body can sustain to produce ATP via oxidative metabolism during prolonged exercise. Per the Fick equation (VO2 = Q × (a-v)O2), it is governed by oxygen delivery (cardiac output, hemoglobin, capillary supply) and muscle extraction (mitochondrial function), and is most often quantified as VO2max. Higher aerobic capacity supports endurance, faster recovery, and metabolic resilience, and tracks closely with healthspan and reduced cardiovascular and all-cause mortality.

Albumin is the most abundant plasma protein, synthesized exclusively by the liver, and maintains colloid osmotic pressure while transporting hormones, fatty acids, calcium, bilirubin, and many drugs. Serum levels reflect hepatic synthetic capacity, nutritional status, inflammation, and renal or gastrointestinal losses. Lower albumin is a robust marker of biological aging and is consistently associated with sarcopenia, frailty, longer hospital stays, and higher all-cause mortality, which is why it features in many composite aging indices.

Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are intracellular enzymes released into blood when hepatocytes are injured. ALT is relatively liver-specific, while AST also originates from muscle, heart, and red blood cells. Elevated values most often reflect metabolic-associated steatotic liver disease, alcohol use, viral hepatitis, or drug toxicity, and the AST/ALT ratio helps distinguish causes. Persistently raised liver enzymes are associated with cardiometabolic risk and higher all-cause mortality.

AMPK (AMP-activated protein kinase) is a cellular energy sensor activated when AMP and/or ADP relative to ATP rise, signaling low energy availability. Once active, it stimulates catabolic pathways like fatty acid oxidation and autophagy while inhibiting anabolic processes such as mTORC1-driven protein synthesis. AMPK activation mimics aspects of caloric restriction, and age-related changes in AMPK signaling can contribute to impaired metabolic regulation. Metformin and exercise are well-known indirect AMPK activators.

Antagonistic pleiotropy, formulated by evolutionary biologist George C. Williams in 1957, holds that genes selected for benefits early in life can cause harm later, after reproduction has occurred. Because selection pressure weakens with age, such alleles persist despite late-life costs. The hypothesis is a foundational explanation for why aging evolved and remains a leading evolutionary framework alongside mutation accumulation and disposable soma theory.

Apolipoprotein B (ApoB) is the structural protein of atherogenic lipoproteins, including LDL, VLDL, IDL, and Lp(a). Because ApoB-100 is typically present as approximately one molecule per atherogenic particle, plasma ApoB serves as a clinical proxy for atherogenic particle number. Multivariable Mendelian randomization (e.g., Richardson et al.) prioritizes ApoB and particle burden as the causal lipid driver of coronary artery disease, making ApoB a more accurate predictor of cardiovascular events and mortality than LDL cholesterol alone. Lower ApoB is associated with reduced atherosclerotic disease.

Apoptosis is a tightly regulated form of programmed cell death in which cells are dismantled in an orderly fashion via caspase activation, typically without triggering inflammation as it is non-lytic and anti-inflammatory relative to necrosis or pyroptosis. It eliminates damaged, infected, or surplus cells and is essential for development, tissue homeostasis, and tumor suppression. Tissue- and context-specific changes in apoptosis with age contribute to impaired clearance of damaged or senescent cells in some tissues and to atrophy and neurodegeneration in others.

Low-dose aspirin (typically 75–100 mg daily) is an irreversible COX-1 inhibitor that suppresses platelet thromboxane A2, reducing platelet aggregation. It is approved for secondary prevention of myocardial infarction and ischemic stroke, where benefit clearly outweighs bleeding risk. The ASPREE trial in healthy older adults showed no cardiovascular benefit, increased major bleeding, and a signal of increased all-cause mortality. Current guidelines discourage routine primary prevention; the USPSTF 2022 recommends individualized decision-making in adults 40–59 with at least 10 percent 10-year CVD risk and recommends against initiation in adults aged 60 or older. Cancer-prevention signals remain investigational.

The autonomic nervous system (ANS) regulates involuntary bodily functions including heart rate, blood pressure, digestion, and respiration. It is traditionally divided into sympathetic (fight-or-flight) and parasympathetic (rest-and-digest) divisions, with the enteric nervous system commonly recognized as a semi-autonomous third division regulating the gastrointestinal tract. In longevity science, ANS function is assessed via HRV, baroreflex sensitivity, and heart rate recovery, since dysautonomia and chronic sympathetic dominance are implicated in cardiovascular disease and accelerated biological aging.

Autophagy is a conserved lysosomal degradation pathway in which cells engulf damaged organelles, misfolded proteins, and other cytoplasmic material in double-membrane vesicles called autophagosomes for recycling (a process most precisely describing macroautophagy, the dominant subtype). By clearing dysfunctional components and recycling amino acids during nutrient stress, it maintains cellular homeostasis. Declining autophagic flux is widely observed with age, though the magnitude is tissue- and context-dependent, and its induction by fasting, exercise, and rapamycin is considered one of the major proposed longevity mechanisms.

BDNF is a growth-factor protein that supports neuronal survival, synapse formation, and — at least in animal models — adult hippocampal neurogenesis (its extent in adult humans remains debated). Levels rise with aerobic exercise and quality sleep; effects of intermittent fasting are well-established in rodents but less clear in humans, and levels fall under chronic stress and depression. In longevity research, lower BDNF is associated with depression and Alzheimer's risk, linking lifestyle to memory and mood regulation.

Berberine is an isoquinoline alkaloid found in multiple plant genera, including Berberis, Hydrastis canadensis (goldenseal), and Coptis chinensis. It is sold as a dietary supplement in most jurisdictions and is not an approved drug in the EU or US. Berberine inhibits mitochondrial complex I, raising the AMP:ATP ratio and thereby activating AMPK downstream; small trials show modest reductions in fasting glucose, HbA1c, LDL cholesterol, and triglycerides in metabolic syndrome and type 2 diabetes. Marketed informally as natural metformin, evidence quality is limited, product purity varies, and CYP3A4-mediated drug interactions warrant caution. Longevity use is investigational.

Biological age is an estimate of how old a person's body appears to be based on physiological and molecular markers, rather than the calendar. It can be derived from blood biomarkers (e.g. PhenoAge), DNA methylation patterns (epigenetic clocks), grip strength, gait speed or organ-specific proteomic signatures. Although widely used in longevity research, no single biological-age measure is yet endorsed by regulators as a clinical endpoint, and validation varies strongly between methods.

Blue Zones are regions reported to have unusually many centenarians. The popularly cited list (Buettner) includes Okinawa (Japan), Sardinia (Italy), Nicoya (Costa Rica), Ikaria (Greece), and Loma Linda (USA), while the demographically validated set typically comprises Sardinia, Okinawa, Nicoya, Ikaria, and sometimes Martinique. Shared features include plant-based diets, moderate caloric intake, low-intensity movement, strong social ties, and purpose. Saul Newman has argued that supercentenarian counts may be inflated by age-record errors, pension fraud, and missing birth registries.

Box breathing is a paced breathing technique using equal-length phases of inhale, hold, exhale, and hold (commonly four seconds each). Slowing respiration well below the typical 12–16 breaths per minute is associated with increased vagal tone and heart-rate variability in slow- and resonance-breathing studies. It is widely taught in military, clinical, and performance settings for acute stress regulation. Direct RCT evidence for box breathing as a distinct protocol is limited; most support is extrapolated from broader paced/slow-breathing research.

BPC-157 is a synthetic 15-amino-acid peptide derived from a sequence in human gastric juice, marketed for tendon, ligament, and gut healing. Animal studies suggest pro-angiogenic and tissue-repair effects, but human clinical-trial data are very limited, comprising only a small number of pilot studies with no large well-controlled RCTs. It is not approved by the FDA or EMA, has been added to FDA restriction lists, and is prohibited at all times under WADA category S0 (Unapproved Substances), as it has not been approved by any governmental health authority for human therapeutic use.

Caloric restriction is a sustained reduction in energy intake, typically 10–30% below ad libitum, without malnutrition. It activates conserved nutrient-sensing pathways including AMPK and sirtuins while suppressing mTOR and insulin/IGF-1 signaling. In many rodent models it extends lifespan, though effects vary by strain, sex, age at onset, and protocol; non-human primate trials gave divergent results (Wisconsin vs. NIA). In humans, the CALERIE-2 trial (~12% achieved restriction, below the 25% target) improved cardiometabolic markers and reduced inflammation.

Cardiorespiratory fitness (CRF) is the ability of the circulatory and respiratory systems to deliver oxygen to working muscles during sustained activity, most often quantified by VO2max. It integrates lung function, cardiac output, vascular health, and muscle oxidative capacity. Some large cohort studies (e.g., Mandsager et al. 2018) suggest low CRF can carry mortality risk comparable to or greater than smoking, hypertension, or diabetes, making CRF a powerful modifiable longevity predictor.

Cellular reprogramming is the experimental conversion of one cell type into another, most often a differentiated somatic cell into a pluripotent stem cell, by forcing expression of specific transcription factors such as OSKM. The process resets the epigenome, including DNA methylation and histone marks, effectively reversing many molecular age signatures. It underpins iPSC technology and is being explored as a route to organ regeneration and systemic rejuvenation.

Cellular senescence is a stable cell-cycle arrest triggered by stressors such as DNA damage, telomere dysfunction, oncogene activation or oxidative stress. Senescent cells remain metabolically active and typically secrete a pro-inflammatory mixture of cytokines, chemokines and proteases known as the SASP. While senescence initially suppresses tumour formation and aids wound healing, the accumulation of senescent cells with age contributes to tissue dysfunction and age-related disease.

A centenarian is a person who has reached the age of 100 years or more. Centenarians are a key research population in longevity science because they typically delay or escape major age-related diseases. Studies such as the New England Centenarian Study and Japans Okinawa Centenarian Study examine genetic, lifestyle, and environmental factors associated with exceptional human lifespan and healthspan.

Chromatin is the complex of DNA, histones, and associated proteins that packages the genome inside the nucleus. Its basic unit, the nucleosome, can be tightly compacted as heterochromatin or loosely arranged as euchromatin, controlling which genes are accessible for transcription. Chromatin organisation safeguards genomic stability and cellular identity. Loss of heterochromatin and disorganised chromatin architecture are recognised hallmarks of ageing and contribute to cellular dysfunction.

Chronological age is the time elapsed since a person's birth, usually measured in years. It is the standard reference variable in demography, medicine and epidemiology and remains one of the strongest single predictors of mortality and many age-associated conditions. Unlike biological age, chronological age does not capture variation in physiological decline between individuals; two people of the same chronological age may differ markedly in functional capacity, disease risk and remaining healthspan, and depending on cohort and endpoint other measures can match or exceed its predictive value.

Chronotype is the individual disposition toward earlier or later sleep-wake timing, commonly described as morning, intermediate, or evening type. It is shaped by genetics, age, light exposure, and social schedules. Chronotype influences cognitive peak times, athletic performance, and cardiometabolic risk, and a mismatch with imposed work or school hours, known as social jetlag, has been linked to obesity, mood disorders, and impaired metabolic health.

The circadian rhythm is the body's roughly 24-hour internal cycle that coordinates sleep-wake timing, hormone release, body temperature, and metabolism. It is governed by the suprachiasmatic nucleus in the hypothalamus and entrained primarily by light exposure. Stable circadian alignment supports cardiometabolic health, immune function, and cognitive performance, while chronic disruption is linked to obesity, type 2 diabetes, and accelerated biological aging.

Coenzyme Q10 (ubiquinone) is a lipid-soluble molecule essential for mitochondrial electron transport and ATP production, and an intracellular antioxidant. Endogenous levels decline with age and with statin use. Clinical evidence is strongest in heart failure, where supplementation is associated with reduced mortality and improved symptoms in some trials. Effects on blood pressure and statin-related muscle symptoms are modest; longevity benefits in healthy adults are not established.

Cognitive reserve, developed and formalised by Yaakov Stern building on earlier brain-reserve work (Katzman and colleagues, late 1980s), refers to the brain's functional adaptability — built through education, complex work, multilingualism, and lifelong learning. It is distinguished from brain reserve, the structural or biological capacity often operationalised via measures of brain integrity and size. Higher cognitive reserve is associated with better cognitive outcomes for a given level of pathology. In longevity science, it is a central modifiable target of brain-health interventions, helping postpone dementia symptoms.

Cold exposure is the deliberate use of cold air, water, or ice (cold showers, ice baths, cryotherapy) as a hormetic stressor. Acute cold triggers noradrenaline release and peripheral vasoconstriction and, if sufficiently intense, shivering thermogenesis; some protocols are non-shivering by design. It may activate brown adipose tissue, though BAT activation in humans varies substantially with the exposure protocol and detection method. Reported effects include improved cold tolerance and subjective alertness; evidence for metabolic, immune, and longevity benefits in humans remains limited and mixed.

Cold thermogenesis is the body's heat-producing response to cold, comprising shivering thermogenesis in skeletal muscle and non-shivering thermogenesis driven by UCP1-dependent activation of brown and other thermogenic ('beige') adipose depots. Repeated cold stimulation can increase tracer-based glucose uptake by thermogenic adipose tissue in small imaging studies, though this reflects local activity rather than necessarily systemic metabolic improvement. Whether these effects translate into durable, clinically meaningful improvements in body composition or metabolic health remains under investigation.

Compression of morbidity is a concept introduced by James Fries in 1980 describing a scenario in which the onset of chronic disease and disability is postponed faster than the increase in lifespan, so that severe illness is concentrated into a shorter period at the end of life. It is a guiding goal of geroscience and healthspan-oriented medicine. Empirical evidence is mixed: in some populations morbidity has compressed, in others it has expanded as lifespan rose.

A continuous glucose monitor (CGM) is a wearable sensor, typically inserted into subcutaneous tissue, that measures interstitial glucose every few minutes, typically about 7 to 14 days for transcutaneous sensors (system-dependent), and up to a year for implantable devices such as Eversense 365. It generates trend data on fasting, postprandial, and nocturnal glucose, time-in-range, and glycemic variability. CGMs are increasingly used in non-diabetic adults to personalize nutrition and inform longevity-oriented lifestyle adjustments.

The coronary artery calcium (CAC) score is a non-contrast cardiac CT measurement reported as an Agatston score that quantifies calcified atherosclerotic plaque as a marker of total atherosclerotic burden; non-calcified (soft) plaque is not detected. A higher CAC score is strongly associated with future myocardial infarction, cardiovascular events, and all-cause mortality, and primary-prevention guidelines (2018 ACC/AHA, 2021 ESC) recommend CAC for risk reclassification in intermediate-risk adults. A score of zero indicates very low short-term event risk but does not fully exclude atherosclerosis, particularly in younger adults or those with elevated Lp(a) or familial hypercholesterolemia.

The cortisol awakening response (CAR) is a sharp rise in salivary cortisol of roughly 50 percent on average (commonly reported in the range of about 38 to 75 percent) from the awakening sample to a peak about 30 to 45 minutes after waking. It reflects healthy hypothalamic-pituitary-adrenal axis activation, mobilising energy and focus for the day. A blunted or exaggerated CAR is associated with chronic stress, burnout, depression, sleep disorders, and adverse cardiometabolic outcomes, making it a useful marker in longevity and stress research.

Creatinine is a breakdown product of muscle creatine, produced at a relatively constant rate and cleared predominantly by glomerular filtration with a small contribution from tubular secretion, making serum creatinine a core marker of renal function. Because absolute values depend on muscle mass, age, sex, dietary meat intake, and creatine supplementation, laboratories report estimated glomerular filtration rate (eGFR) using the 2021 race-free CKD-EPI equation as current standard. Lower eGFR indicates reduced filtration capacity and is robustly associated with cardiovascular events, frailty, and mortality.

CRON is a structured form of caloric restriction in which energy intake is reduced by roughly 20–30% while micronutrient density (vitamins, minerals, essential fatty acids, protein quality) is deliberately maximized. The approach was developed by Roy Walford, Lisa Walford, and Brian M. Delaney, with The Anti-Aging Plan (1994) as a key reference, and later promoted by the CR Society. The aim is to capture metabolic benefits—improved insulin sensitivity, lower inflammation, favorable lipids—without inducing nutrient deficiencies.

Curcumin is the principal polyphenol in turmeric (Curcuma longa) and modulates NF-kB, Nrf2, and other inflammatory and oxidative pathways. Standard curcumin has very low oral bioavailability; supplements typically use piperine, phospholipid, or nanoparticle formulations. Meta-analyses suggest modest reductions in inflammatory markers, joint pain, and lipid measures, but effects vary by formulation and study quality. Evidence for direct longevity benefits in humans is limited.

D+Q is one of the most studied senolytic combinations: dasatinib (a tyrosine-kinase-inhibitor cancer drug) plus quercetin (a flavonoid), given intermittently and designed to selectively eliminate or reduce senescent-cell burden. Preclinical studies show improvements in physical function and tissue health in aged mice. Human data are limited to small pilot trials in IPF, diabetic kidney disease, and frailty, which have shown reductions in senescence markers; efficacy as an anti-aging therapy remains unproven and use is off-label.

Deep sleep, or slow-wave sleep (N3), is the stage characterised by high-amplitude delta waves on EEG and the highest arousal threshold. It dominates the first third of the night and drives growth hormone release, cardiovascular recovery, immune regulation, and glymphatic clearance of metabolic waste. Deep sleep declines with age, and lower amounts are associated with poorer memory and increased risk of neurodegenerative disease.

Dehydroepiandrosterone sulfate (DHEA-S) is the sulfated, long-circulating form of DHEA, secreted by the adrenal cortex (zona reticularis) and serving as a precursor to androgens and estrogens in peripheral tissues. Although it has minor diurnal variation, serum levels are far more stable than DHEA itself, making DHEA-S the preferred clinical marker of adrenal androgen output. It peaks in early adulthood and declines steeply with age (adrenopause); lower values are observationally associated with frailty, reduced bone density, and impaired immune function, though DHEA supplementation trials have largely been null for hard outcomes.

The disposable soma theory, proposed by Thomas Kirkwood in 1977, posits that organisms allocate finite metabolic resources between somatic maintenance and reproduction. Because natural selection favors reproductive success, the body invests only enough in repair to survive likely environmental hazards, leaving residual damage that accumulates as aging. The theory remains influential in evolutionary biogerontology and underlies modern thinking on caloric restriction and trade-offs.

DNA damage refers to chemical or structural alterations of the genome, including base modifications, single- and double-strand breaks, and crosslinks. It arises from reactive oxygen species, ionising radiation, UV light, and replication stress. Cells respond through DNA damage repair pathways; when overwhelmed, damage triggers senescence, apoptosis, or mutations. Genomic instability driven by accumulated DNA damage is a recognised hallmark of ageing and a cancer driver.

DNA methylation is an epigenetic modification in which methyl groups are added to cytosine bases, predominantly at CpG sites, by DNA methyltransferases. It regulates gene expression, X-inactivation, and genome stability without altering the underlying sequence. Methylation patterns shift predictably with age, forming the basis of epigenetic clocks such as Horvath's. Aberrant methylation contributes to cancer, immune dysfunction, and the broader epigenetic drift seen in ageing.

DunedinPACE (Pace of Aging Calculated from the Epigenome) is an epigenetic clock published in 2022 by Belsky and colleagues that estimates the rate of biological ageing rather than a static age. It was trained in the Dunedin 1972-1973 birth cohort on longitudinal change across 19 organ-system biomarkers and translated into a DNA-methylation score using 173 CpGs. The score is calibrated so that 1 represents the cohort-mean pace of one year of biological aging per chronological year; values above 1 indicate faster-than-average ageing. DunedinPACE shows good test-retest reliability and predicts morbidity and mortality.

Dynapenia is the age-related loss of muscle strength and power that occurs independently of muscle mass loss. The term was coined by Clark and Manini (2008) to distinguish age-related strength loss from sarcopenia, which historically centred on muscle mass. It reflects neurological decline — fewer motor units, slower firing rates, reduced central drive — rather than just atrophy. Because strength predicts mortality more strongly than mass, dynapenia is now considered a distinct geriatric risk factor; power-focused training is the primary countermeasure.

Eccentric training emphasizes the lengthening phase of a muscle contraction, such as the lowering portion of a squat or curl. Muscles produce greater force eccentrically than concentrically, generating high mechanical tension with relatively low metabolic cost. This makes eccentric work effective for building strength, hypertrophy, and tendon stiffness, and it is widely used in tendinopathy rehabilitation. Older adults tolerate it well, though delayed-onset muscle soreness is common.

EGCG is the most abundant catechin in green tea and a polyphenol with antioxidant, anti-inflammatory, and AMPK-modulating activity. Observational data link green tea consumption to lower cardiovascular and all-cause mortality. Trials of EGCG supplements show small effects on lipids, blood pressure, and body weight, with high-dose extracts associated with hepatotoxicity in rare cases. Direct evidence for human longevity from isolated EGCG remains limited.

Epigenetic age is a biological-age estimate derived from DNA-methylation patterns at selected CpG sites, computed by algorithms known as epigenetic clocks (e.g. Horvath, Hannum, PhenoAge, GrimAge, DunedinPACE). The difference between epigenetic and chronological age, called epigenetic age acceleration, is associated with mortality, cardiovascular disease and cancer in research cohorts. Validation depends on the specific clock; first-generation clocks track chronological age, while mortality-trained clocks better predict health outcomes. Commercial consumer tests vary in reliability.

Epigenetic alterations are age-related changes in DNA methylation patterns, histone modifications, chromatin architecture and non-coding RNA expression that occur without changes to the underlying DNA sequence. With age, the epigenome typically shows global hypomethylation alongside focal hypermethylation, loss of heterochromatin and altered transcription. These shifts underpin epigenetic clocks such as the Horvath and GrimAge clocks, which estimate biological age and predict mortality more accurately than chronological age.

EPOC is the elevated oxygen uptake that persists after exercise ends, as the body restores ATP and creatine phosphate, clears lactate, refills oxygen stores, and returns hormones and temperature to baseline. The effect is largest after high-intensity or resistance work and modestly increases total energy expenditure. Although often called the afterburn, EPOC is best understood as a physiological recovery process rather than a primary fat-loss mechanism.

Estradiol (E2) is the most biologically active estrogen, produced mainly in the ovaries before menopause and in smaller amounts via aromatization of androgens in adipose tissue, brain, bone, liver, breast, and other peripheral tissues. It supports endothelial function, bone turnover, reproductive tissues, and may support cognition. After menopause, levels drop sharply and remaining production occurs via peripheral aromatization, contributing to accelerated bone loss, vasomotor symptoms, and a multifactorial rise in cardiometabolic risk. In men, modest estradiol from aromatization is important for bone health.

Fasting glucose is the plasma blood-sugar concentration after at least eight hours without caloric intake. It reflects baseline glucose homeostasis driven by hepatic glucose output, β-cell insulin secretion, peripheral insulin sensitivity, and counter-regulatory hormones such as glucagon, with renal glucose handling as a further contributor. Persistently elevated values indicate impaired fasting glucose, prediabetes, or type 2 diabetes, and Mendelian randomization supports a causal effect of higher fasting glucose on coronary disease. Even within the upper-normal range, rising fasting glucose tracks with increased risk, so stable lower-normal values are generally favorable.

Fasting insulin measures circulating insulin after an overnight fast and reflects β-cell output, hepatic insulin clearance, and peripheral insulin sensitivity together. Elevated fasting insulin is one of the earliest signs of insulin resistance and often appears before fasting glucose or HbA1c rise, consistent with the natural history seen in cohorts such as Whitehall II and IRAS. Hyperinsulinemia is associated with metabolic syndrome, type 2 diabetes, and a higher risk of cardiovascular disease and all-cause mortality. Lower fasting insulin generally indicates better insulin sensitivity and metabolic flexibility.

The fasting-mimicking diet is a 5-day low-calorie, low-protein, plant-based regimen developed by Valter Longo's group that reproduces metabolic effects of water-only fasting—reduced IGF-1, glucose, and insulin; elevated ketones—while still providing some food. Pivotal trials used 3 cycles spaced one month apart and reported improvements in cardiometabolic risk markers and abdominal adiposity. Suggested benefits on biological age estimates rest on secondary analyses (Brandhorst et al. 2024) and should be considered preliminary.

Fisetin is a flavonoid found in strawberries, apples, and persimmons. In aged mice, Yousefzadeh et al. (2018) reported reduced senescent cell burden and extended median lifespan using a specific intermittent dosing protocol, though independent replication remains limited. Mechanisms include induction of apoptosis in senescent cells and modulation of inflammatory pathways, making it a candidate dietary senolytic under investigation. Human trials are ongoing, and clinical evidence in people remains preliminary.

Flow, described by psychologist Mihaly Csikszentmihalyi, is a state of deep absorption in a challenging activity matched to one's skill, accompanied by reduced self-awareness and altered time perception. It is a popular wellbeing concept whose subjective experience is well-documented, while neural correlates remain debated. For longevity it is relevant because regular flow correlates with life satisfaction, sustained engagement, and the kind of meaningful activity that supports cognitive aging.

FOXO transcription factors (Forkhead box O) are downstream effectors of the insulin/IGF-1 pathway that regulate genes governing stress resistance, DNA repair, autophagy, and antioxidant defense. When insulin/IGF-1 signaling is low, FOXO enters the nucleus and activates protective transcriptional programs. FOXO3 variants are among the most reproducibly associated genetic markers of human exceptional longevity, observed across centenarian cohorts in multiple ethnicities.

The free radical theory of aging, proposed by Denham Harman in 1956, originally attributed aging to cumulative cellular damage from oxygen-derived free radicals, drawing on rate-of-living and oxygen-toxicity reasoning. Harman's 1972 update, the mitochondrial free radical theory of aging (MFRTA), specifically implicated mitochondrial ROS and mtDNA as the central drivers. While oxidative damage is undeniably involved, large antioxidant trials largely failed, and the theory is now considered partial. Modern frameworks integrate it with mitochondrial dysfunction and redox signaling.

Free radicals are atoms or molecules carrying one or more unpaired electrons, which makes them highly reactive. They arise from normal metabolism, immune activity, and external sources such as UV radiation, pollution, and tobacco smoke. By stealing electrons from neighbouring molecules, free radicals damage membranes, enzymes, and DNA. The free-radical theory of ageing posits that this cumulative damage contributes to functional decline and age-related disease.

Free T3 (fT3) and free T4 (fT4) are the unbound, biologically active fractions of triiodothyronine and thyroxine. T4 is the main thyroid secretion product and is deiodinated peripherally to the more potent T3, which acts on nuclear receptors to regulate metabolism, thermogenesis, and cardiovascular function. Measuring free fractions avoids interference from binding-protein changes and helps distinguish primary thyroid disease, central hypothyroidism, and non-thyroidal illness when interpreted alongside TSH.

Gene therapy delivers genetic material to add, silence, or edit genes — typically via AAV vectors for stable transgene expression and lipid nanoparticles for transient nucleic-acid delivery (e.g., mRNA, gene-editing components). Longevity targets include telomerase (TERT), follistatin, Klotho, and partial reprogramming via OSK (Oct4, Sox2, Klf4 — three Yamanaka factors, omitting c-Myc to reduce oncogenicity). Rodent data are strong for some constructs, but human applications remain pre-clinical or run as small offshore or patient-paid programs outside FDA-regulated frameworks (BioViva, Libella). Risks include immunogenicity, oncogenicity, and off-target editing; no anti-aging gene therapy is approved.

Genomic instability is the progressive accumulation of damage to nuclear and mitochondrial DNA, including point mutations, chromosomal rearrangements, copy-number changes and retrotransposon activation. It arises from endogenous sources such as replication errors and reactive oxygen species as well as exogenous insults like UV light and toxins, and is exacerbated by declining DNA-repair capacity. As one of the primary hallmarks of ageing, it drives clonal expansion, cancer risk and tissue dysfunction.

Gerontology is the scientific study of aging across biological, psychological, and social dimensions. Established as a formal discipline in the early 20th century, with Ilya Mechnikov coining the term in 1903, it encompasses biogerontology, social gerontology, and geriatric medicine. It remains the broader umbrella field within which geroscience focuses specifically on molecular and cellular mechanisms relevant to disease prevention.

Geroscience is an interdisciplinary field that investigates the biological mechanisms of aging and their causal links to chronic disease. Coined around 2007 by researchers at the Buck Institute and formalized by the NIH-led Geroscience Interest Group, it rests on the premise that targeting aging itself can simultaneously delay multiple age-related conditions. It now underpins translational efforts like the TAME trial.

Gamma-glutamyl transferase (GGT) is a membrane-bound enzyme that transfers gamma-glutamyl groups and supports glutathione recycling, with highest activity in liver, biliary epithelium, and kidney. Serum GGT rises with cholestasis, alcohol intake, hepatic steatosis, and many enzyme-inducing drugs, making it a sensitive but unspecific liver marker. Beyond hepatology, higher GGT within the reference range is independently associated with insulin resistance, cardiovascular disease, and increased all-cause mortality, marking oxidative stress.

GLP-1 receptor agonists (e.g. liraglutide, semaglutide, dulaglutide) mimic the incretin hormone glucagon-like peptide-1, stimulating glucose-dependent insulin secretion, suppressing glucagon, slowing gastric emptying, and reducing appetite. Approved indications include type 2 diabetes and obesity; large trials show reduced cardiovascular events and, more recently, kidney and heart-failure benefits. Longevity-relevant effects include weight loss, improved glycemia, and possible neuroinflammatory dampening. Off-label use purely for healthspan extension in metabolically healthy adults remains investigational.

Glucose variability quantifies the magnitude and frequency of blood glucose fluctuations over hours and days, typically expressed as standard deviation, coefficient of variation, or mean amplitude of glycemic excursions (MAGE). High variability is implicated in oxidative stress, endothelial dysfunction, and diabetic complications independent of mean glucose. In non-diabetic adults, lower variability correlates with better metabolic health, and continuous glucose monitoring increasingly tracks it as a longevity-relevant biomarker.

Glycation is the non-enzymatic attachment of sugars such as glucose or fructose to proteins, lipids, or nucleic acids. Through the Maillard reaction it generates unstable Schiff bases, then Amadori products, and ultimately advanced glycation end-products. Glycation stiffens collagen, impairs enzyme activity, and disrupts cell signalling. Driven primarily by hyperglycaemia and elevated glycaemic load, it accelerates skin ageing, vascular stiffening, and diabetic complications.

The glymphatic system, described by Iliff, Nedergaard and colleagues in 2012, is the brain's waste-clearance pathway, in which cerebrospinal fluid flows along perivascular spaces, exchanges with interstitial fluid, and removes metabolic byproducts such as beta-amyloid and tau. Activity increases substantially during deep sleep, when the interstitial space expands by roughly 60 percent (Xie et al., 2013). Impaired glymphatic clearance is implicated in Alzheimer's disease and other neurodegenerative conditions, making sleep a key intervention point for brain longevity.

GrimAge is a second-generation epigenetic clock introduced by Lu et al. (2019, with Steve Horvath as senior author). Instead of predicting chronological age, it is trained on time-to-death and combines DNA-methylation surrogates for seven plasma proteins (e.g. PAI-1, GDF-15) and DNAm-based smoking pack-years. In multiple cohorts GrimAge and the updated GrimAge2 (2022) outperform earlier clocks at predicting all-cause mortality, cardiovascular disease and cancer. It is widely used in research; clinical use as a diagnostic endpoint remains investigational.

Grip strength is the maximal force generated when squeezing a dynamometer and serves as a low-cost proxy for whole-body muscular function. In the 17-country PURE cohort (Leong et al., Lancet 2015; ~140,000 adults), each 5 kg decrement in grip strength predicted roughly a 16% increase in all-cause mortality, outperforming systolic blood pressure as a mortality predictor. It correlates with neuromuscular health, nutritional status, and recovery capacity, making it one of the most validated biomarkers of biological aging.

The Hallmarks of Aging are a set of interconnected biological processes proposed by López-Otín and colleagues to describe the molecular and cellular drivers of ageing. The 2023 update lists twelve hallmarks, including genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, disabled macroautophagy, chronic inflammation and dysbiosis. They serve as the dominant framework for longevity research and intervention design.

The Hayflick limit is the maximum number of times a normal human somatic cell can divide in culture, typically 40 to 60 times, before entering replicative senescence. Discovered by Leonard Hayflick in 1961, the limit is mechanistically explained by progressive telomere shortening with each division. It established that aging has a cell-intrinsic component and remains a foundational concept linking cellular replication, telomere biology, and organismal aging.

HbA1c (glycated hemoglobin) reflects the proportion of hemoglobin stably bound to glucose, providing an integrated estimate of average blood glucose over approximately the prior 2 to 3 months, with the most recent ~30 days contributing roughly half of the signal per published kinetic models. It is the primary biomarker for diagnosing and monitoring type 2 diabetes (threshold 6.5%) and prediabetes (5.7 to 6.4%). HbA1c is influenced by erythrocyte lifespan, anemia, and hemoglobin variants.

HDL cholesterol (high-density lipoprotein cholesterol) measures the cholesterol carried by HDL particles, which transport cholesterol from tissues back to the liver in reverse cholesterol transport. Population studies historically associated higher HDL-C with lower cardiovascular risk, but Mendelian randomization and HDL-raising drug trials show the relationship is non-causal and U-shaped: very high HDL-C is also linked to increased mortality. HDL functionality matters more than its concentration alone.

Healthspan is the period of life spent in good health, free from serious chronic disease and major functional impairment. It is conceptually distinct from lifespan, which counts total years lived. In longevity research healthspan is increasingly preferred as an outcome because the goal is to compress the years of frailty and disease at the end of life. Operational definitions vary and may use disease-free survival, disability indices or composite biomarker scores.

Heart rate variability is the beat-to-beat fluctuation in time between successive heartbeats, measured in milliseconds. Within a healthy sinus rhythm, higher values typically reflect stronger vagal modulation and cardiovascular adaptability, but pathologically high beat-to-beat variability (e.g. atrial fibrillation or frequent ectopic beats) does not indicate good autonomic health and must be excluded before interpretation. Declining HRV trends are associated with aging, chronic stress, and elevated all-cause mortality risk.

Heat shock proteins (HSPs) are a family of highly conserved molecular chaperones, named for their induction by heat but active under many forms of stress. They assist protein folding, prevent aggregation, attempt to refold denatured proteins when possible, and route irreparable ones for degradation. HSPs such as HSP70 and HSP90 are central to proteostasis, and HSP induction by exercise and heat exposure (including sauna) is studied as one contributing mechanism among many for their health effects.

The heat shock response is a conserved cellular program triggered by elevated temperature and other proteotoxic stressors. Heat shock factor 1 (HSF1) activates transcription of heat shock proteins (HSPs) such as HSP70 and HSP90, which act as chaperones to refold or degrade damaged proteins. This pathway supports proteostasis and is hypothesised to mediate hormetic benefits of sauna and exercise; direct human longevity evidence remains preliminary.

HIIT alternates short bouts of near-maximal effort with periods of low-intensity recovery, typically over 10–30 minutes total. The high-intensity intervals stress cardiac output and mitochondrial function, driving rapid gains in VO2max, insulin sensitivity, and stroke volume. Compared with steady-state cardio, HIIT delivers similar or greater cardiorespiratory adaptations in less time, making it a time-efficient longevity intervention when balanced with lower-intensity aerobic work.

Hippocampal volume measures the size of the brain region central to memory consolidation and spatial navigation. Atrophy rates vary by cohort and method: Jack et al. report roughly 1.55 percent per year in cognitively normal controls, accelerating to about 3.98 percent per year in Alzheimer's disease. MRI-derived volume serves as an early biomarker of cognitive aging. Aerobic exercise has been shown to preserve or even enlarge it (Erickson et al. 2011, PNAS), while separate lines of evidence link sleep quality and chronic stress to hippocampal structure.

Histone modifications are reversible chemical changes to histone proteins around which DNA is wound, including acetylation, methylation, phosphorylation, and ubiquitination. They reshape chromatin structure and recruit regulatory complexes, thereby controlling gene transcription, DNA repair, and replication. The combined pattern is often called the histone code. Age-related shifts in histone marks contribute to epigenetic drift, loss of cellular identity, and dysregulated stress and longevity pathways.

HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is a fasting blood index calculated as (fasting insulin in µU/mL × fasting glucose) / k, where k = 22.5 if glucose is in mmol/L (SI units) or k = 405 if glucose is in mg/dL (US conventional units). It estimates whole-body insulin resistance from fasting measures, predominantly reflecting hepatic insulin action, as a low-cost surrogate for clamp methods. Cutoffs are population- and assay-dependent, with no universal threshold; values are commonly cited around 2 to 2.9 in adults.

Homocysteine is a sulfur-containing amino acid produced during methionine metabolism and cleared via remethylation or transsulfuration pathways that depend on folate, vitamin B12, and vitamin B6. Elevated plasma homocysteine reflects impaired one-carbon metabolism and is associated with vascular endothelial dysfunction, atherosclerosis, and stroke; cognitive decline and dementia are observationally associated, but causality is uncertain. Major randomized trials of B-vitamin lowering (HOPE-2, NORVIT, VISP, SEARCH, VITATOPS) have not consistently reduced cardiovascular events overall, though some meta-analyses suggest a small reduction in stroke risk. Homocysteine is therefore interpreted as a risk and metabolic-health marker.

Hormesis is a biphasic dose-response phenomenon in which a low or moderate dose of a stressor produces a beneficial adaptive effect, while higher doses are harmful. Mild stressors such as heat, cold, exercise, fasting, or certain phytochemicals can involve activation of defence and adaptive pathways such as Nrf2, heat-shock proteins and AMPK in some settings, with the precise response depending on dose, tissue and context. In longevity research, hormesis is one mechanistic framework, alongside others, for why intermittent stress can extend healthspan in model organisms.

Menopausal HRT replaces estrogen, typically combined with a progestogen in women with a uterus, to relieve vasomotor symptoms, protect bone, and treat genitourinary symptoms. Per WHI re-analyses and the timing hypothesis, the benefit-risk profile is more favorable when initiated within roughly ten years of menopause or before age 60. VTE risk is greater with oral estrogen than with transdermal preparations, and breast cancer risk is greater with combined estrogen+progestogen than estrogen-alone, rising with duration. It is symptom- and risk-directed therapy, not a proven life-extension intervention.

The Horvath clock is a multi-tissue epigenetic age estimator published by Steve Horvath in 2013. It uses DNA methylation levels at 353 CpG sites to predict chronological age across more than 50 tissues and cell types with a median error of about 3.6 years. It is the most-cited epigenetic clock and well validated as a predictor of chronological age, but its association with mortality and disease is weaker than that of later, mortality-trained clocks such as GrimAge.

High-sensitivity C-reactive protein (hs-CRP) is a liver-produced acute-phase protein, induced primarily by IL-6, and measured with an assay sensitive enough to detect low-grade systemic inflammation. Outside acute infection, persistently elevated hs-CRP signals chronic inflammation linked to atherosclerosis, insulin resistance, and metabolic syndrome. hs-CRP is a downstream marker of IL-6–driven inflammation; Mendelian randomization does not support CRP itself as causal for coronary heart disease, while trials targeting upstream inflammation (e.g., CANTOS with canakinumab) reduce cardiovascular events. It remains a useful marker of inflammatory burden associated with cardiovascular and mortality risk.

Hyperbaric oxygen therapy delivers 100% oxygen at pressures typically of 2.0–2.4 atmospheres absolute (with the clinical threshold for HBOT generally defined as at least 1.4 ATA) inside a pressurised chamber, dramatically increasing dissolved oxygen in plasma. It is an established treatment for decompression sickness, carbon monoxide poisoning, and selected non-healing wounds. Off-label longevity uses (telomere length, cognition, anti-ageing) rely on small trials with methodological limits; current evidence does not support routine use for healthy ageing.

Hypoxia training exposes the body to reduced oxygen, either continuously (altitude, hypoxic tents) or intermittently (cycles of low and normal oxygen). Reported adaptations include stabilisation of hypoxia-inducible factor (HIF), and the practice may increase EPO/erythropoiesis and has been associated with mitochondrial adaptations, though magnitude depends strongly on hypoxic dose, duration, and individual factors. Used by endurance athletes and studied for cardiometabolic and cognitive applications, the evidence is heterogeneous, and intermittent hypoxia carries risks particularly in obstructive sleep apnea or certain cardiovascular conditions.

Insulin-like growth factor 1 (IGF-1) is produced mainly in the liver under growth hormone stimulation and mediates many anabolic GH effects on muscle, bone, and other tissues. As a biomarker it serves as a stable surrogate for GH activity and reflects nutritional status and protein intake. Higher levels in adulthood are linked to greater cancer risk, while very low levels are associated with frailty and reduced lean mass, suggesting a U-shaped relationship with longevity.

IGF-1 signaling refers to the cascade triggered when insulin-like growth factor 1 binds the IGF-1 receptor, activating parallel PI3K/AKT and MAPK/ERK branches that promote cell growth, proliferation, and protein synthesis while suppressing FOXO-driven stress resistance. IGF-1 can also engage insulin/IGF-1R hybrid receptors at lower affinity. Reduced IGF-1 signaling extends lifespan in worms, flies, and mice, and lower circulating IGF-1 is observed in some long-lived human cohorts. The trade-off between growth/repair benefits and longevity costs remains actively debated.

Ikigai is a Japanese concept loosely translated as a sense of purpose or reason for being, encompassing everyday sources of meaning — relationships, routines, small pleasures — as described by Japanese scholars such as Mieko Kamiya. The popular four-circle Venn diagram (what you love / are good at / can be paid for / what the world needs) is not Japanese in origin: it was created by blogger Marc Winn in 2014 by relabeling Andrés Zuzunaga's unrelated 2011 Spanish purpose diagram, and has no documented connection to Okinawa. The underlying construct of life purpose has been linked in observational studies (e.g., Sone et al. 2008, Ohsaki cohort) to lower cardiovascular mortality.

Inflammaging describes the chronic, low-grade, sterile inflammation that develops with age in the absence of overt infection. It is characterised by often elevated baseline levels of pro-inflammatory mediators such as IL-6, TNF-alpha and CRP, driven by senescent cells, accumulated cellular debris, gut dysbiosis and immune dysregulation. Inflammaging is a recognised hallmark of ageing and, in many studies, an independent risk factor associated with increased risk of cardiovascular disease, neurodegeneration, frailty, sarcopenia and overall mortality.

Insulin resistance is a state in which target tissues respond poorly to insulin, prompting the pancreas to secrete more to maintain glucose homeostasis. Driven by visceral adiposity, ectopic fat in liver and muscle, chronic inflammation, and inactivity, it underlies prediabetes, type 2 diabetes, metabolic syndrome, and metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD). Insulin resistance is also associated with accelerated cardiovascular aging, cognitive decline, and shortened healthspan.

Insulin sensitivity describes how effectively cells, especially in muscle, liver, and adipose tissue, respond to insulin to take up glucose and suppress hepatic glucose output. Higher sensitivity allows lower circulating insulin to maintain normoglycemia, reducing strain on pancreatic beta cells. It is improved by physical activity, sleep, low visceral fat, and dietary fiber. Robust insulin sensitivity is a hallmark of metabolic health and longevity-relevant resilience.

The insulin/IGF-1 pathway (often abbreviated IIS) is a conserved nutrient-sensing network in which insulin and IGF-1 bind tyrosine kinase receptors to activate PI3K, AKT, and mTOR while inhibiting FOXO. It coordinates glucose uptake, growth, and anabolic metabolism with nutrient availability. Loss-of-function mutations along this pathway dramatically extend lifespan in C. elegans (daf-2), Drosophila, and mice, establishing IIS as a foundational longevity pathway across the animal kingdom.

Intermittent fasting is an umbrella term for eating patterns that alternate normal intake with extended fasting windows, including 16:8 time-restricted eating, alternate-day fasting, and 5:2 protocols. Fasting periods lower insulin and glycogen, trigger lipolysis and ketogenesis, and induce autophagy. Clinical trials show modest improvements in body composition, glycemic control, and blood pressure; meta-analyses suggest results are broadly comparable to matched continuous calorie reduction, though some trials report small advantages for visceral fat or insulin sensitivity.

Induced pluripotent stem cells (iPSCs) are adult somatic cells reprogrammed into a pluripotent state using factors such as OSKM, capable of differentiating into any cell type of the body. They bypass the ethical concerns of embryonic stem cells and enable patient-specific disease modeling, drug screening, and autologous cell therapies. In aging research, iPSCs reset many epigenetic age markers, providing a powerful platform to study and reverse cellular aging.

Isometric training involves contracting muscles against an immovable resistance without joint movement, as in planks, wall sits, or holding a mid-range squat. It builds tendon stiffness and joint-angle-specific strength while imposing minimal mechanical stress, making it useful in rehabilitation. A 2023 network meta-analysis (Edwards et al., Br J Sports Med) of 270 randomized trials found isometric exercise — particularly wall sits — produced the largest reductions in resting systolic (~8 mmHg) and diastolic (~4 mmHg) blood pressure among studied modalities, including aerobic and dynamic-resistance training.

The ketogenic diet is a very-low-carbohydrate (typically <50 g/day), high-fat, moderate-protein eating pattern that drives the body into sustained nutritional ketosis. Originally developed to treat refractory pediatric epilepsy, it is now studied for type 2 diabetes, obesity, and neurodegenerative conditions. Mechanisms include lower insulin, improved metabolic flexibility, and ketone-mediated signaling. Long-term effects on lipid profiles, kidney function, and adherence remain under active investigation.

Ketone bodies are three water-soluble molecules—β-hydroxybutyrate, acetoacetate, and acetone—produced in hepatocyte mitochondria from acetyl-CoA derived from fatty acid β-oxidation when carbohydrate availability is low. Beyond serving as efficient ATP fuel for brain and heart, β-hydroxybutyrate is an endogenous signaling molecule that inhibits class I histone deacetylases, dampens NLRP3 inflammasome activity, and may improve mitochondrial efficiency, mechanisms relevant to fasting biology and longevity research.

Ketosis is a metabolic state in which the liver converts fatty acids into ketone bodies—β-hydroxybutyrate, acetoacetate, and acetone—that serve as alternative fuel for brain, heart, and muscle when glucose is scarce. It is induced by fasting, prolonged exercise, or very-low-carbohydrate diets, with blood β-hydroxybutyrate typically rising above the 0.5 mmol/L nutritional-ketosis threshold (Volek/Phinney). β-hydroxybutyrate also acts as a signaling molecule, inhibiting class I HDACs and modulating inflammation.

Klotho (here referring to alpha-Klotho, distinct from beta-Klotho) is a transmembrane protein, predominantly expressed in the kidney and brain, that also circulates as a soluble hormone after cleavage. It regulates phosphate and vitamin D homeostasis via FGF23 co-receptor function and modulates several signaling pathways including insulin/IGF-1, Wnt, and others. Klotho-deficient mice show accelerated aging phenotypes, while Klotho overexpression extends lifespan. Higher circulating Klotho levels in humans are associated with better cognitive performance and reduced cardiovascular and renal disease risk.

Lactate threshold is used loosely for two points: LT1 (aerobic threshold, ~2 mmol/L), where blood lactate first rises above baseline, and LT2, the highest intensity sustainable without progressive accumulation. LT2 is often approximated by OBLA, a fixed ~4 mmol/L criterion, or by MLSS, the highest steady-state workload — these correlate but are not identical, and absolute values vary by protocol and individual. Training near these thresholds increases mitochondrial enzymes and lactate clearance, raising sustainable workload.

LDL cholesterol (low-density lipoprotein cholesterol) reflects the cholesterol carried by LDL particles in the bloodstream. Excess ApoB-containing LDL particles can enter and be retained in the arterial intima, where modification (e.g., oxidation) and inflammation drive atherosclerotic plaque formation. LDL-C is a long-established causal risk factor for atherosclerotic cardiovascular disease, heart attack, and stroke; lifelong genetically lower LDL-C (e.g., PCSK9 loss-of-function variants) reduces ASCVD risk dose-dependently. From a longevity perspective LDL-C is lower-is-better, ideally interpreted alongside ApoB and Lp(a), as LDL-C and ApoB can be discordant.

Lifespan is the total length of time an organism lives, from birth to death, typically expressed in years for humans. In population terms it is summarised by life expectancy at birth or at a given age. Maximum lifespan refers to the longest documented age reached within a species; for humans this is around 122 years. Lifespan is influenced by genetics, environment, behaviour and access to medical care, and is a classic outcome in longevity research.

Loneliness, the subjective feeling of social disconnection, is now recognised as an independent risk factor for cardiovascular disease, dementia, and early mortality. Meta-analyses by Holt-Lunstad and colleagues (2010, 2015) found social isolation and loneliness raise all-cause mortality risk by roughly 26 to 32 percent — an effect she has compared by analogy to smoking up to 15 cigarettes a day. It dysregulates inflammation, sleep, and HPA-axis stress responses. In longevity science, addressing loneliness through community, purpose, and relationships is a primary, evidence-based intervention.

Longevity escape velocity describes a hypothetical threshold at which medical advances extend remaining life expectancy by more than one year per calendar year, effectively outrunning aging. Popularized by biogerontologist Aubrey de Grey in the early 2000s, it remains a speculative concept rather than an empirically validated milestone. Mainstream geroscience treats it as an aspirational framing rather than a near-term forecast.

Loss of proteostasis is one of the established hallmarks of aging and describes the age-related decline of the protein quality control network. Chaperones become less efficient, the proteasome and autophagy slow down, and misfolded or aggregation-prone proteins accumulate. The resulting proteotoxicity contributes to neurodegenerative disorders, cardiac amyloidosis, and cellular dysfunction across tissues, making proteostasis enhancers an active longevity research target.

Lipoprotein(a) is an LDL-like particle in which apolipoprotein(a) is covalently linked to apoB-100 via a disulfide bond. Plasma levels are largely (often cited around 70–90%) genetically determined and usually stable across adulthood, although modest changes can occur with menopause, kidney disease, or inflammation. Mendelian randomization at the LPA locus supports a causal role for elevated Lp(a) in myocardial infarction, ischemic stroke, and calcific aortic valve stenosis. Because diet and lifestyle barely influence it, Lp(a) should be measured at least once to stratify lifetime cardiovascular risk.

The lysosome is a membrane-bound organelle filled with acidic hydrolases that degrade proteins, lipids, nucleic acids, and carbohydrates delivered via endocytosis, phagocytosis, or autophagy. Beyond digestion, it acts as a metabolic and signaling hub that senses nutrients through the mTORC1 pathway. Lysosomal dysfunction underlies storage diseases and contributes to aging by impairing autophagy, clearance of lipofuscin, and overall cellular waste management.

Maximum heart rate (HRmax) is the highest beats per minute the heart reaches during all-out exertion. It is largely determined by age and genetics, not fitness, and declines with age. HRmax sets training zones for Zone 2 and HIIT. The classic 220 minus age formula is rough; Tanaka (208 − 0.7 × age) outperforms it, especially in older adults, but direct measurement in a maximal test remains the gold standard.

The Mediterranean diet is an eating pattern emphasizing vegetables, fruits, legumes, whole grains, nuts, olive oil, and fish, with moderate dairy and limited red meat. Rich in monounsaturated fats, fiber, and polyphenols, it is associated with lower systemic inflammation, improved lipid profiles, and better endothelial function. Long-term adherence is associated in cohort studies and the PREDIMED trial (which tested Mediterranean diet supplemented with extra-virgin olive oil or mixed nuts; retracted and republished in 2018) with reduced cardiovascular events, type 2 diabetes risk, and all-cause mortality.

Melatonin is a hormone secreted by the pineal gland in response to darkness, signalling biological night and helping align the circadian system. It facilitates sleep onset, modulates core body temperature, and exerts antioxidant effects. Endogenous melatonin declines with age, and bright evening light suppresses its release. Low-dose exogenous melatonin is used to address jet lag, shift work, and delayed sleep-phase patterns.

Metabolic flexibility is the capacity of cells and the whole organism to switch efficiently between fuel sources—primarily glucose and fatty acids—in response to feeding, fasting, and physical activity. It depends on intact mitochondrial function, insulin sensitivity, and hormonal signaling. Loss of flexibility, marked by impaired fasting fat oxidation and postprandial glucose handling, is a hallmark of insulin resistance, obesity, and aging, and is a key target of fasting and exercise interventions.

Metformin is a biguanide oral antidiabetic drug, first-line therapy for type 2 diabetes mellitus. It lowers hepatic gluconeogenesis and improves insulin sensitivity, partly via mitochondrial complex I inhibition and indirect AMPK activation. Observational data suggest reduced all-cause mortality and cancer incidence in diabetics, motivating the TAME trial in non-diabetic older adults. Off-label longevity use remains investigational; benefit in metabolically healthy people is unproven and may even blunt exercise adaptations.

Defined by Petersen's diagnostic criteria (objective cognitive decline on testing, preserved daily functioning, not meeting dementia threshold), mild cognitive impairment exceeds normal aging without impairing independence. Roughly 10 to 15 percent of people with MCI progress to dementia each year in clinic-based cohorts, with lower rates in community samples. In longevity medicine it is a critical intervention window: lifestyle changes, treatment of vascular risk, sleep optimisation, and hearing correction can stabilise or partially reverse symptoms.

The MIND diet (Mediterranean-DASH Intervention for Neurodegenerative Delay) is a hybrid eating pattern targeting brain health. It emphasizes leafy greens, berries, nuts, whole grains, beans, fish, poultry, and olive oil while limiting red meat, butter, cheese, pastries, and fried food. Observational studies link higher adherence to slower cognitive decline and lower Alzheimer's incidence, though a 2023 randomized trial showed only modest cognitive effects over three years.

Mindfulness is the trained practice of bringing non-judgmental attention to present-moment experience, typically through meditation. Randomised trials show modest but consistent benefits for stress, anxiety, depression, chronic pain, and blood pressure. Some studies have linked long-term mindfulness practice to longer leukocyte telomeres and modestly reduced inflammatory markers, though findings are inconsistent and effect sizes are small. It remains a low-risk adjunct to standard brain-health and cardiometabolic interventions.

Mitochondrial biogenesis is the process by which cells increase mitochondrial mass and capacity by coordinating the expression of nuclear and mitochondrial genes. The transcriptional coactivator PGC-1-alpha is a key nodal regulator, regulated by AMPK and SIRT1 among other signals. Endurance exercise, caloric restriction, and cold exposure are well-established physiological stimuli, and robust biogenesis is associated with muscular endurance, metabolic flexibility, and healthy aging.

Mitochondrial density refers to the number and volume of mitochondria per unit of muscle tissue. Higher density expands oxidative capacity, allowing more fatty acids and pyruvate to be burned aerobically and improving endurance and metabolic flexibility. Aerobic and Zone 2 training stimulate mitochondrial biogenesis via PGC-1α, while age and inactivity reduce it. Maintaining mitochondrial density is considered central to healthy aging and cardiorespiratory fitness.

Mitochondrial dysfunction refers to a decline in mitochondrial efficiency, including reduced ATP output, impaired electron transport chain activity, increased reactive oxygen species, and altered mitochondrial dynamics. It is recognized as a hallmark of aging and is implicated in sarcopenia, type 2 diabetes, neurodegeneration, and cardiovascular disease. Interventions under study include exercise, NAD+ precursors, urolithin A, and senolytics, while extreme antioxidant supplementation has not shown longevity benefit.

Mitophagy is the selective form of autophagy that targets damaged or depolarized mitochondria for lysosomal degradation, with the PINK1/Parkin pathway being the best-characterized route alongside PINK1/Parkin-independent receptor pathways. By removing dysfunctional mitochondria, it can help limit oxidative stress and support bioenergetic function. Impaired mitophagy is linked to neurodegeneration, sarcopenia, and cardiovascular aging, and compounds such as urolithin A are studied for effects consistent with enhanced mitophagy markers, including in older and middle-aged adults.

mTOR (mechanistic target of rapamycin) is a serine/threonine kinase that integrates signals from amino acids, growth factors, and cellular energy status to regulate protein synthesis, cell growth, and autophagy. It functions in two complexes, mTORC1 and mTORC2. Chronic mTORC1 hyperactivation accelerates aging phenotypes, while pharmacologic inhibition with rapamycin extends lifespan in multiple model organisms, making mTOR one of the most validated longevity targets.

NAD+ (nicotinamide adenine dinucleotide, oxidized form) is a coenzyme central to redox reactions in energy metabolism and a required substrate for sirtuins, PARPs, and CD38. Cellular NAD+ levels decline substantially with age across tissues, impairing mitochondrial function, DNA repair, and sirtuin activity. NAD+ precursors such as NR (nicotinamide riboside) and NMN (nicotinamide mononucleotide) are studied as supplements aimed at restoring tissue NAD+, with mixed clinical evidence.

NADH is the reduced form of NAD+, generated when NAD+ accepts electrons during glycolysis, the citric acid cycle, and fatty acid oxidation. It delivers electrons to the mitochondrial electron transport chain, driving ATP synthesis. The cellular NAD+/NADH ratio reflects metabolic state and influences sirtuin activity, redox signaling, and substrate selection. A shifted ratio toward NADH, often observed in aging and metabolic disease, is associated with reductive stress and mitochondrial dysfunction.

NEAT is the energy expended during all daily activity outside of structured exercise — walking, standing, fidgeting, household chores, and posture maintenance. It can vary by up to ~2,000 kilocalories per day between individuals of similar body size and often exceeds the contribution of formal workouts to total energy balance. Higher NEAT is associated with lower visceral adiposity, improved metabolic health, and reduced sedentary-time mortality risk, making it a meaningful longevity lever.

Negligible senescence describes organisms that show no measurable functional decline, increase in mortality risk, or loss of reproductive capacity with chronological age. The term was popularized by biogerontologist Caleb Finch in 1990 to characterize species such as certain rockfish, naked mole-rats, and hydra. It is studied as a comparative biology benchmark for understanding why most mammals, including humans, do age.

Neuroplasticity is the brain's lifelong capacity to reorganise its structure and synaptic connections in response to learning, experience, and injury. It underpins memory formation, recovery from stroke, and skill acquisition at any age. For longevity, neuroplasticity is the mechanism by which exercise, novel learning, social engagement, and sleep protect cognitive function and slow age-related decline.

NMN is a nucleotide and NAD+ precursor in the salvage pathway, feeding into a coenzyme central to energy metabolism, sirtuin activity, and DNA repair. Oral NMN is absorbed and raises blood NAD+ in humans, but evidence for clinical longevity benefits remains limited. Trials report modest improvements on specific endpoints such as the 6-minute walk test, muscle insulin sensitivity, or grip strength; large, long-term outcome studies are lacking.

NR is a vitamin B3 form and NAD+ precursor that is metabolized via salvage pathways to increase NAD+, with NMN as a possible intermediate. Human trials reliably show that oral NR raises blood NAD+ and/or related metabolites and is well tolerated. Evidence for downstream clinical benefits, such as improved physical performance, metabolic health, or healthspan, is mixed and largely confined to small, short-duration studies.

Overtraining syndrome (OTS) sits on a continuum with functional overreaching (FOR) and non-functional overreaching (NFOR), per ECSS/ACSM consensus. It is a maladaptive state in which prolonged training load exceeds recovery capacity, causing unexplained performance decline over weeks to months alongside fatigue, mood disturbances, and sleep disruption. Downward HRV trends, rising resting heart rate, and disproportionate RPE for a given workload are commonly observed but non-specific, and parasympathetic indices may paradoxically rise rather than fall in some athletes.

Oxidative stress is an imbalance between reactive oxygen species production and the body's antioxidant defences, leading to oxidative damage of biomolecules. It impairs mitochondrial function, accelerates telomere attrition, and drives chronic low-grade inflammation. Implicated in many hallmarks of ageing, oxidative stress is associated with cardiovascular disease, neurodegeneration, diabetes, and cancer, and is modulated by diet, exercise, sleep, and environmental exposures.

p16INK4a is a cyclin-dependent kinase inhibitor encoded by the CDKN2A locus that blocks CDK4/6, halting cell cycle progression and enforcing cellular senescence. Its expression rises markedly with chronological age across many tissues, making it a widely used biomarker of senescent cell burden and biological aging. Selective elimination of p16-positive senescent cells (senolysis) extends healthspan in mice, motivating ongoing senolytic drug development for age-related disease.

Parasympathetic activation refers to engagement of the rest-and-digest branch of the autonomic nervous system, primarily mediated by the vagus nerve to thoracic and upper-abdominal organs, with additional outflow via pelvic splanchnic nerves to lower GI and urogenital organs. It slows heart rate, lowers blood pressure, promotes digestion, and supports recovery while modulating inflammatory tone via the cholinergic anti-inflammatory pathway. Slow paced breathing, meditation, and deep sleep raise parasympathetic tone, reflected in higher RMSSD. Cold-water face immersion engages the vagus via the dive reflex, while whole-body cold is primarily a sympathetic stressor with a parasympathetic rebound.

Partial reprogramming uses transient or low-dose expression of Yamanaka factors to rejuvenate cells without erasing their differentiated identity or inducing pluripotency. Studies in mice show restoration of youthful epigenetic patterns, improved tissue regeneration, and extended healthspan. Because full reprogramming risks teratoma formation, partial protocols aim to capture rejuvenation benefits while preserving cell function. It is an active and contested frontier in longevity research, with safety and durability still under investigation.

Peptide therapy uses short amino-acid chains, often injected, intended to modulate growth hormone (e.g., sermorelin, ipamorelin), tissue repair, or metabolism. A few peptides are approved for narrow indications, but most longevity uses are off-label or sourced as research chemicals. Human evidence for anti-aging endpoints is sparse, quality control of compounded products is variable, and regulatory bodies (e.g., FDA) have restricted several popular peptides.

PhenoAge is a composite biological-age measure developed by Levine and colleagues in 2018. The original blood-based version combines nine clinical biomarkers including albumin, creatinine, glucose, C-reactive protein and white blood cell count with chronological age, calibrated against mortality. A DNA-methylation version, DNAm PhenoAge, transfers the score to epigenetic data. PhenoAge predicts all-cause mortality and multimorbidity better than chronological age and has been validated in several large cohorts, although clinical use is still emerging.

Photobiomodulation, often called red light therapy, applies low-level red and near-infrared light to tissue; most clinical devices use ~600–900 nm, with some PBM literature extending toward ~1100 nm. The proposed mechanism likely involves multiple pathways, including absorption by cytochrome c oxidase in mitochondria, nitric oxide signalling, and broader mitochondrial redox modulation, which together influence ATP production and reactive oxygen species. Clinical evidence supports modest benefits for some skin and musculoskeletal conditions; broader anti-ageing, cognitive, or metabolic claims rest on small or preliminary trials and are not yet established.

Plasmapheresis is the umbrella term for extracorporeal procedures that separate plasma from cellular blood components; technique varies, with plasma either fractionated or filtered and partially returned, or wholly removed and replaced as in TPE. It is established for autoimmune and hyperviscosity disorders, where its dominant mechanism is removal of pathogenic plasma factors such as antibodies, immune complexes, and inflammatory mediators. In longevity contexts it is proposed to dilute pro-aging plasma factors, but evidence for healthy-aging benefit is preliminary.

Plyometrics are explosive movements — jumps, hops, bounds, throws — that exploit the stretch-shortening cycle, in which a rapid eccentric load primes a powerful concentric contraction. They train rate of force development, neuromuscular coordination, and tendon elasticity. In ageing populations, low-volume jump training improves bone mineral density, balance, and reactive strength, addressing the power deficit that drives falls. Progression and surface choice matter to manage joint load.

Polyvagal theory, proposed by Stephen Porges in 1994, posits that distinct vagal branches — a phylogenetically newer ventral-vagal complex and an older dorsal vagal pathway — evolved in mammals to support social engagement versus shutdown/freeze responses. It is widely used in trauma therapy and somatic practice, but its comparative-neuroanatomy and evolutionary claims have been substantively challenged in peer-reviewed work (Grossman & Taylor 2007; Grossman 2023), and mainstream neuroscience does not treat it as established. The well-supported finding that vagal tone (HRV) and breathing influence health does not depend on polyvagal theory and should not be conflated with it.

Postprandial glucose refers to blood glucose levels after a meal, often peaking around 60 minutes (typically within 1 to 2 hours) before returning toward fasting baseline. The size and duration of the spike reflect carbohydrate quantity and quality, gastric emptying, insulin response, and tissue uptake. Recurrent large excursions (a value rarely exceeded in non-diabetics is roughly 140 mg/dL) are associated, in a graded fashion, with vascular risk and cardiovascular disease, making postprandial control a key target in metabolic and longevity-oriented nutrition.

Progressive overload is the principle of gradually increasing training demands — load, volume, density, range of motion, or proximity to failure — to keep driving adaptation. Without it, the body settles into a maintenance state and gains plateau. The progression must be small enough to be tolerated and large enough to be meaningful. It is the central mechanism behind sustained gains in strength, hypertrophy, and bone density across a training career.

Prolonged fasting refers to fasting periods of roughly 48 hours up to several days during which only water, electrolytes, and sometimes minimal calories are consumed. After glycogen depletion, the body shifts to fatty acid oxidation and ketogenesis, suppresses IGF-1 and mTOR, and upregulates autophagy. Stem-cell-based regeneration has been demonstrated in rodents; human translation remains limited. Risks include electrolyte disturbances and refeeding syndrome, so prolonged fasting should be medically supervised.

Protein crosslinks are covalent bonds that join two protein molecules or different segments of the same protein. They can form enzymatically, as with collagen maturation, or non-enzymatically through oxidation and glycation by sugars and reactive aldehydes. Pathological crosslinks accumulate in long-lived structural proteins like collagen, elastin, and crystallins, stiffening tissues. This contributes to vascular rigidity, skin ageing, cataracts, and reduced organ elasticity.

Proteostasis, short for protein homeostasis, is the integrated network that controls protein synthesis, folding, trafficking, and degradation to keep the proteome functional. Key players include ribosomes, molecular chaperones, the ubiquitin-proteasome system, and autophagy-lysosome pathways. Maintaining proteostasis is essential for cellular function; its progressive failure with age underlies neurodegenerative diseases such as Alzheimer's and Parkinson's and is recognized as a hallmark of aging.

Quercetin is a flavonoid abundant in onions, apples, capers, and berries with antioxidant and anti-inflammatory activity. It is investigated as a senolytic, though standalone activity is inconsistent in human cell models; the combination with dasatinib (D+Q) is the regimen actually studied in early human senolytic trials. Standalone supplementation has shown small, inconsistent blood pressure effects mainly in hypertensive populations, and bioavailability is low. Human anti-aging evidence is preliminary.

Rapamycin (sirolimus) is a macrolide mTORC1 inhibitor approved as an immunosuppressant to prevent kidney transplant rejection and to treat lymphangioleiomyomatosis. By inhibiting mTORC1, it slows protein synthesis, enhances autophagy, and extends lifespan in yeast, worms, flies, and mice across multiple labs. Off-label use for human longevity remains investigational; clinical trials are evaluating intermittent low-dose protocols, but efficacy and long-term safety in healthy adults are unproven.

Reactive oxygen species are oxygen-containing molecules such as superoxide, hydrogen peroxide, and hydroxyl radicals produced by multiple cellular sources, including mitochondrial respiration, NADPH oxidases, peroxisomes, and the immune respiratory burst. At low levels they act as signalling molecules regulating immunity and metabolism, but excess ROS damages lipids, proteins, and DNA. Chronic ROS accumulation contributes to mitochondrial decline, cellular senescence, and age-related diseases including cardiovascular and neurodegenerative disorders.

A readiness score is a vendor-defined daily index, popularized by devices like Oura and Garmin (whose analogous metric is branded Training Readiness or Body Battery), that aims to indicate how prepared the body is for physical or cognitive load. Whoop's analogous metric is branded Recovery, not Readiness. It typically blends HRV, resting heart rate, body temperature deviation, sleep quality, and prior strain. Algorithms differ by manufacturer and lack peer-reviewed standardization, so values should be treated as proprietary longitudinal signals rather than clinically validated measures.

Recovery score is a generic category for vendor-defined composite metrics that estimate how well the body has recuperated from prior strain. Branding differs by device: Whoop calls its score Recovery, Garmin uses Body Battery and Training Readiness, and Oura uses Readiness. Inputs commonly include HRV, resting heart rate, respiratory rate, sleep duration, and sleep stages, though exact algorithms are proprietary. There is no scientific consensus on a standardized recovery score; values are not directly comparable across devices and should be interpreted as vendor-specific trends rather than diagnostic measurements.

Regenerative medicine is the field developing therapies to repair, replace, or regenerate damaged cells, tissues, and organs. Approaches include stem cell transplantation, tissue engineering, gene therapy, organoids, biomaterial scaffolds, and cellular reprogramming. By restoring lost function rather than only managing symptoms, it aims to address age-related degeneration, organ failure, and chronic disease. It is closely intertwined with longevity science, where reversing cellular and tissue aging is a central therapeutic objective.

The reliability theory of aging, advanced by Leonid and Natalia Gavrilov in the early 1990s, applies engineering reliability mathematics to biological systems. It models organisms as redundant networks of components that fail stochastically; aging arises as redundancy depletes, producing the observed Gompertz mortality curve. The theory elegantly explains late-life mortality plateaus and provides a quantitative bridge between molecular damage and population-level survival data.

REM (rapid eye movement) sleep is a sleep stage marked by fast eye movements, vivid dreaming, near-waking brain activity, and skeletal muscle atonia. It increases toward the second half of the night and supports memory consolidation, emotional processing, and synaptic plasticity. Reduced REM duration has been associated in epidemiological studies with higher all-cause mortality, cognitive decline, and impaired mood regulation.

Resting heart rate (RHR) is the number of heartbeats per minute at full rest, ideally measured supine after several minutes of quiet rest or upon waking, and is influenced by caffeine, illness, medications, and sleep. Trained individuals typically have lower RHR primarily through elevated vagal/parasympathetic tone, with increased stroke volume as a secondary cardiac adaptation. Epidemiological data (e.g., Aune 2017) link elevated RHR with higher cardiovascular and all-cause mortality, making it a simple biomarker of cardiorespiratory health and recovery.

Resveratrol is a stilbene polyphenol found in grape skins, red wine, and Japanese knotweed. It is studied as a putative sirtuin (SIRT1) activator and AMPK modulator, with effects on inflammation and mitochondrial function in preclinical models. Human trials have produced inconsistent results, and oral bioavailability is poor. There is currently no robust evidence that resveratrol supplementation extends human lifespan or healthspan.

RMSSD (Root Mean Square of Successive Differences) is a time-domain HRV metric defined as the square root of the mean of the squared successive differences between adjacent NN (or RR) intervals, expressed in milliseconds. It is considered the most reliable short-term marker of parasympathetic (vagal) activity and is widely used in wearables and rPPG-based readings. In longevity research, RMSSD is tracked as a daily indicator of recovery, training adaptation, sleep quality, and acute stress load.

Rate of perceived exertion (RPE) is a subjective scale used to quantify how hard physical exercise feels, most commonly on the 6–20 Borg scale or the 0–10 modified scale. It correlates reasonably well with heart rate, lactate, and VO2 in trained individuals. RPE is widely used in longevity and endurance protocols to autoregulate training load, manage fatigue, and complement objective recovery metrics like HRV and resting heart rate.

Sarcopenia is the age-related loss of skeletal muscle mass, strength, and function; contributing factors include anabolic resistance, neuromuscular changes, chronic inflammation, and inactivity. Under the EWGSOP2 (2019) consensus, low muscle strength (grip strength or chair-stand) is the primary criterion for probable sarcopenia, confirmed by low muscle quantity or quality (DXA, BIA, CT/MRI), with poor physical performance defining severity. Since October 2016 it has its own ICD-10-CM code (M62.84), recognising it as an independent clinical condition.

The senescence-associated secretory phenotype, or SASP, is the complex mixture of cytokines, chemokines, growth factors, proteases and extracellular vesicles released by senescent cells. It is regulated by multiple pathways, prominently including NF-kB, with mTOR, cGAS-STING, p38 MAPK and C/EBPbeta also influencing SASP output in certain contexts. Depending on context, the SASP can recruit immune cells to clear damaged tissue or, when persistent, fuel chronic low-grade inflammation, fibrosis and paracrine senescence in neighbouring cells, making it a key mechanistic link between cellular senescence and age-related disease.

A Finnish sauna is a dry-heat bath, typically 80–100°C with low humidity, used as a passive heat-stress modality. Acute sessions raise core temperature and produce a cardiovascular response (e.g. increased heart rate and peripheral vasodilation) that overlaps with some aspects of exercise, but is not equivalent to aerobic training. Large Finnish cohort studies, often categorising sessions as 1, 2–3, and 4–7 per week, link frequent use with lower cardiovascular and all-cause mortality, with the lowest risk in the 4–7 group; data are observational and causal effects on longevity are not established.

SDNN (Standard Deviation of NN intervals) is a time-domain HRV measure capturing the overall variability of normal heartbeats. Per HRV Task Force standards, SDNN is primarily reported over 24-hour recordings, where it reflects both sympathetic and parasympathetic influences along with circadian rhythms and longer-term low-frequency variability that contributes to 24-h SDNN. Short-term 5-min SDNN is heavily influenced by respiratory/vagal variability, though RMSSD and HF power are more specific markers of vagal modulation. Low 24-hour SDNN is associated with increased cardiovascular and all-cause mortality risk, particularly post-infarction.

Semaglutide is a long-acting GLP-1 receptor agonist approved for type 2 diabetes (Ozempic, Rybelsus) and chronic weight management (Wegovy). The SELECT trial demonstrated a 20 percent reduction in major adverse cardiovascular events in adults with obesity and established cardiovascular disease without diabetes. Longevity-relevant mechanisms include sustained weight loss, improved insulin sensitivity, lower inflammation, and possible cognitive and renal protection. Off-label use solely for lifespan extension in healthy adults is investigational and not endorsed.

Senolytic therapy uses drugs or natural compounds to selectively eliminate senescent cells, which accumulate with age and secrete a multi-component secretome (the SASP) of inflammatory cytokines and chemokines, growth factors, and tissue-remodeling proteases such as MMPs. By targeting senescent-cell anti-apoptotic pathways (SCAPs) and promoting selective apoptosis in these cells, senolytics aim to reduce age-related dysfunction. Evidence is robust in animal models, but human trials remain small and early; clinical efficacy, optimal dosing, and long-term safety are unproven.

Senolytics are compounds that selectively induce cell death in senescent cells by exploiting context-specific survival vulnerabilities, including BCL-2 family proteins, PI3K/AKT signalling and disruption of pro-survival complexes such as the FOXO4-p53 interaction. The vulnerabilities targeted are heterogeneous and compound-specific. Studied candidates include the dasatinib plus quercetin combination, fisetin and navitoclax. In animal models, intermittent senolytic dosing improves physical function and extends healthspan, but human evidence is still limited to early-phase trials and clinical use outside studies is not established.

Senomorphics, also called senostatics, are compounds that suppress the harmful secretory activity of senescent cells without killing them. They typically target signalling pathways that drive the SASP, including NF-kB, mTOR, JAK/STAT and p38 MAPK. Examples studied preclinically include rapamycin, metformin, ruxolitinib and certain flavonoids. The aim is to reduce chronic inflammation and tissue damage from senescent cells while preserving any beneficial roles they may have in wound healing and tumour suppression.

SGLT2 inhibitors (gliflozins, e.g. empagliflozin, dapagliflozin) block renal sodium-glucose cotransporter 2, causing urinary glucose excretion. They are approved for type 2 diabetes, heart failure (preserved and reduced ejection fraction), and chronic kidney disease, with robust cardiovascular and renal mortality benefits. Proposed mechanisms include a hypothesized ketone-mediated cardiac fuel shift, mild caloric loss, and reduced glomerular hyperfiltration, though the dominant pathway remains debated. Canagliflozin extended lifespan in male mice. Off-label longevity use in non-indicated adults remains investigational.

Sirtuins are a family of seven NAD+-dependent enzymes (SIRT1–SIRT7) that deacetylate or otherwise modify proteins involved in metabolism, DNA repair, mitochondrial function, and stress response. Their activity depends on cellular NAD+ availability, linking nutrient status to gene regulation. Sirtuins are implicated in caloric restriction's longevity effects, though direct lifespan extension by sirtuin activators in mammals remains debated. SIRT1, SIRT3, and SIRT6 receive the most aging-related research attention.

The sit-rise test measures the ability to lower oneself to the floor and stand back up using as little support as possible, scored from zero to ten with points deducted for hand, knee, or balance assistance. It captures lower-body strength, flexibility, balance, and body composition in a single movement. In Brito and Araújo's cohort of 2,002 adults aged 51–80 (Eur J Prev Cardiol, 2014), low scores (0–3) carried roughly 2–5× higher all-cause mortality than high scores (8–10), with each additional point linked to ~21% lower mortality risk over a median follow-up of 6.3 years.

Sleep apnea is a disorder of repeated breathing pauses or shallow breathing events (apneas and hypopneas) during sleep, most commonly obstructive sleep apnea from upper-airway collapse, less often central sleep apnea from disrupted respiratory drive. The AASM diagnoses it at an apnea-hypopnea index of at least 5 per hour with symptoms, or at least 15 without. Untreated, it raises the risk of hypertension, atrial fibrillation, stroke, type 2 diabetes, cognitive decline, and all-cause mortality.

Sleep efficiency is the percentage of time spent asleep relative to the total time in bed, calculated as total sleep time divided by time in bed. Values of 85 percent or higher are generally regarded as healthy in adults. Low sleep efficiency reflects fragmented or inefficient sleep and is associated with daytime fatigue, impaired glucose metabolism, elevated cardiovascular risk, and poorer subjective quality of life.

Sleep latency is the time from lights-out to the first epoch of sleep, typically measured in minutes during polysomnography. A latency of about 10 to 20 minutes is considered healthy; very short latencies (under roughly 5 to 8 minutes) can indicate sleep deprivation or excessive daytime sleepiness, while persistently longer values suggest insomnia or circadian misalignment. It is a core metric in polysomnography and consumer sleep trackers used in longevity contexts.

Spermidine is a naturally occurring polyamine found in wheat germ, aged cheese, soy, and mushrooms, though content varies widely by source and processing. It induces autophagy, the cellular recycling process implicated in aging, and extends lifespan in yeast, flies, and mice. In humans, dietary intake correlates with lower mortality in observational data; limited preliminary trials have explored possible cognitive signals, but results are not definitive. Causal effects on human longevity are not yet established.

Statins (HMG-CoA reductase inhibitors, e.g. atorvastatin, rosuvastatin) lower hepatic cholesterol synthesis and upregulate LDL receptors, reducing circulating LDL cholesterol. They are approved for primary and secondary prevention of atherosclerotic cardiovascular disease, with strong randomized evidence for reduced cardiovascular mortality. Longevity-relevant pleiotropic effects include endothelial improvement, anti-inflammatory action, and possible plaque stabilization. In low-risk individuals, the absolute mortality benefit is small and less certain; benefit is most clearly demonstrated in higher-risk and secondary prevention populations. Off-label use purely for longevity is investigational.

Stem cell exhaustion is the age-related decline in the number, function, and regenerative capacity of tissue-resident stem cells. Drivers include accumulated DNA damage, telomere attrition, epigenetic drift, mitochondrial dysfunction, and a deteriorating niche environment. Consequences include impaired wound healing, anemia, immunosenescence, sarcopenia, and reduced tissue homeostasis. Recognized as a hallmark of aging, it is a key target for regenerative and reprogramming-based interventions.

Strength training is structured exercise that loads muscles against resistance — free weights, machines, bands, or bodyweight — to drive neural adaptation and muscle protein synthesis. Beyond building muscle and bone, it improves insulin sensitivity, mitochondrial function, and metabolic health. In longevity research, regular resistance training is consistently linked to lower all-cause mortality, preserved independence in later life, and reduced risk of frailty and falls.

Sulforaphane is an isothiocyanate generated when broccoli, broccoli sprouts, and other cruciferous vegetables are chewed or chopped. It activates the Nrf2 pathway, upregulating antioxidant and phase II detoxification enzymes. Human studies report effects on biomarkers of oxidative stress, inflammation, and cardiometabolic risk, with promising but mixed signals in autism and cancer chemoprevention. Long-term clinical outcomes from sulforaphane supplementation are not yet established.

A supercentenarian is a person verified to have reached the age of 110 years or more. The 110+ threshold and term were popularized chiefly by L. Stephen Coles, founder of the Gerontology Research Group, with demographer James Vaupel contributing complementary validation work through MPIDR and the International Database on Longevity. The cohort numbers only a few hundred globally at any time and is studied for genetic resilience, late-life morbidity compression, and as a benchmark against unverified age claims.

Telomerase is a ribonucleoprotein reverse transcriptase (TERT plus the TERC RNA template) that adds TTAGGG repeats to chromosome ends, counteracting replicative shortening. It is highly active in germline, stem, and most cancer cells but largely silenced in adult somatic tissues. In longevity research, telomerase reactivation has extended healthspan in mice, but it carries oncogenic risk because most human tumors depend on telomerase for unlimited proliferation.

Telomeres are repetitive TTAGGG DNA sequences capping the ends of linear chromosomes, protecting them from degradation, fusion, and erroneous repair. Each somatic cell division shortens telomeres because DNA polymerase cannot fully replicate chromosome ends. Critically short telomeres trigger senescence or apoptosis. Telomere attrition is one of the twelve hallmarks of aging and is associated with cardiovascular disease, immune decline, and reduced regenerative capacity.

Telomere attrition is the progressive shortening of the protective TTAGGG repeat sequences at chromosome ends with each cell division, due to the end-replication problem and oxidative damage. Once telomeres reach a critical length, cells enter replicative senescence or apoptosis via a DNA-damage response. Telomerase, which can extend telomeres, is largely silenced in adult somatic cells. Accelerated attrition is associated with premature ageing syndromes, cardiovascular disease and reduced healthspan.

Testosterone is the principal androgen, produced mainly by Leydig cells in the testes in men and in smaller amounts by the ovaries and adrenals in women. It supports muscle mass, bone density, libido, mood, and erythropoiesis. Laboratories report total testosterone alongside free or bioavailable testosterone, since roughly 98% circulates bound to SHBG and albumin. Levels typically decline with age in men; lower values are observationally associated with sarcopenia, frailty, metabolic syndrome, and higher all-cause mortality and adverse cardiometabolic outcomes, with confounding by obesity, inflammation, and SHBG changes.

TRT restores testosterone in men with documented hypogonadism (low serum testosterone plus symptoms), via gels, injections, or pellets. Benefits include improved libido, mood, lean mass, and bone density. Risks include erythrocytosis, fertility suppression, and possible cardiovascular effects; the recent TRAVERSE trial suggested cardiovascular non-inferiority but not benefit. TRT is not validated as a longevity therapy in eugonadal men and remains controversial outside clinical hypogonadism.

TPE is a specific form of plasmapheresis in which approximately one to one-and-a-half plasma volumes are removed and replaced per session with albumin, saline, or donor plasma, rather than re-infused. It is standard of care for several neurologic and hematologic diseases. Longevity interest stems from rodent dilution studies suggesting rejuvenation; small human trials (e.g., in Alzheimer's) are early and ongoing, with no proven anti-aging benefit.

Time-restricted eating (TRE) confines daily food intake to a consistent window of typically 6–10 hours, leaving 14–18 hours of fasting. The concept emerged from Satchin Panda's circadian biology lab at the Salk Institute. Some trials report improved insulin sensitivity, lipids, and blood pressure independent of calorie reduction; others, including Liu et al. (NEJM 2022), found no advantage of TRE over caloric restriction. Early-window TRE may be preferable, but the evidence remains preliminary.

Tirzepatide is a once-weekly dual GIP and GLP-1 receptor agonist approved for type 2 diabetes (Mounjaro) and chronic weight management (Zepbound). The dual incretin action produces greater weight loss and HbA1c reduction than selective GLP-1 agonists in head-to-head trials, with cardiovascular and sleep apnea benefits emerging. Longevity-relevant effects parallel GLP-1 agonists: improved metabolism, weight reduction, and reduced cardiometabolic risk. Off-label use in metabolically healthy adults for lifespan extension remains investigational.

Triglycerides are the main storage form of dietary and endogenous fat, transported in the blood by triglyceride-rich lipoproteins, mainly VLDL, chylomicrons, IDL, and their remnants. Fasting triglyceride levels rise with insulin resistance, excess refined carbohydrates, alcohol intake, and metabolic syndrome. Elevated values reflect higher concentrations of triglyceride-rich remnant lipoproteins, and remnant cholesterol carried by these particles is causally linked to atherosclerotic cardiovascular disease (Mendelian randomization). Lower fasting triglycerides are associated with better insulin sensitivity and reduced cardiovascular risk.

Thyroid-stimulating hormone (TSH) is released by anterior pituitary thyrotrophs and regulates thyroid hormone production via negative feedback from circulating T3 and T4. In primary thyroid disease it is the most sensitive single marker of thyroid status: higher values typically indicate hypothyroidism, while suppressed values suggest hyperthyroidism or exogenous hormone excess. In central (pituitary or hypothalamic) hypothyroidism, TSH may be inappropriately normal or low alongside low fT4, so combined interpretation with free T4 is required. Reference ranges shift slightly upward with age, and subclinical dysfunction is common in older adults.

The ubiquitin-proteasome system (UPS) is a major route for selective degradation of short-lived, misfolded, or regulatory proteins, complementary to autophagy-lysosomal degradation. Target proteins are tagged with ubiquitin chains via E1 activating, E2 conjugating, and E3 ligase enzymes, with the E3 ligase providing substrate specificity; K48-linked polyubiquitin chains are the canonical proteasome-targeting signal, while other linkages have non-degradative roles. Tagged proteins are then unfolded and degraded into short peptides inside the 26S proteasome. UPS activity declines with age, contributing to loss of proteostasis and neurodegeneration.

Vagal tone describes the baseline activity of the vagus nerve, the primary parasympathetic pathway connecting the brainstem to organs including the heart, lungs, and gut. Higher vagal tone is associated with efficient heart-rate slowing during exhalation, faster post-stress recovery, and lower systemic inflammation. It is commonly estimated from RMSSD or high-frequency HRV. In longevity contexts, strengthening vagal tone through breathwork, exercise, and sleep is considered a modifiable resilience factor.

VO2max is the maximum rate of oxygen consumption during intense exercise, typically expressed in mL/kg/min. Per the Fick principle, it reflects oxygen delivery (cardiac output, hemoglobin) multiplied by muscle extraction at the mitochondria. VO2max is among the strongest predictors of all-cause mortality: higher VO2max is robustly associated with lower long-term risk across cohort studies (e.g., Mandsager 2018), making it a central marker of cardiorespiratory fitness in longevity research.

The Wim Hof method combines cyclic hyperventilation-style breathing, breath holds, and gradual cold exposure, popularised by Dutch athlete Wim Hof. Small studies report transient effects on sympathetic activation, catecholamine release, and short-term immune markers after lipopolysaccharide challenge. Long-term and clinical benefits, including for chronic disease or longevity, remain unproven, and the breath-hold component carries risks of fainting, especially in or near water.

Xenohormesis is the hypothesis that animals benefit from stress-response molecules produced by stressed plants and microbes, sensing them as cues of environmental adversity. Polyphenols such as resveratrol, quercetin, and curcumin are typical examples, proposed to activate sirtuins, AMPK, and other stress-defence pathways, although direct sirtuin activation by resveratrol has been disputed, with much of the in-vivo effect now attributed to AMPK and indirect pathways. Direct evidence that dietary xenohormetic compounds extend human healthspan is still limited.

The Yamanaka factors are four transcription factors, OCT4, SOX2, KLF4, and c-MYC (OSKM), identified by Shinya Yamanaka in 2006 as sufficient to reprogram differentiated somatic cells back into a pluripotent embryonic-like state. This discovery, awarded the 2012 Nobel Prize, demonstrated that cellular identity and aging are reversible. They are now central tools in regenerative medicine, disease modeling, and longevity research focused on epigenetic rejuvenation.

Zone 2 training is sustained aerobic exercise at or just below the first lactate threshold (LT1, ~1.5–2.0 mmol/L), often roughly 60–70% of max heart rate, though the precise percentage varies; lactate testing or the talk-test is more accurate. At this intensity, fat oxidation supplies most energy in slow-twitch fibers, with rising carbohydrate use near the upper end. Regular Zone 2 work increases mitochondrial density, capillarization, and metabolic flexibility.